A carregar...

Development of TRPM8 Antagonists to Treat Chronic Pain and Migraine

A review. Development of pharmaceutical antagonists of transient receptor potential melastatin 8 (TRPM8) have been pursued for the treatment of chronic pain and migraine. This review focuses on the current state of this progress.

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceuticals (Basel)
Main Authors: Weyer, Andy D., Lehto, Sonya G.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5490394/
https://ncbi.nlm.nih.gov/pubmed/28358322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph10020037
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!